Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-4097

Ba/F3-human-FGFR3IIIc-Cell-Line

Home » Ba/F3-human-FGFR3IIIc-Cell-Line

Background of Ba/F3-human-FGFR3IIIc-Cell-Line

FGFR3 is a receptor tyrosine kinase that is a member of the fibroblast growth factor receptor (FGFR) family. Binding of FGF ligands to FGFR3 results in the rapid dimerization and activation of downstream signaling pathways including the PI3K/AKT and MAPK pathways. FGFR3 is most highly expressed in neuronal and sensory cell types and FGFR3 signaling contributes to a variety of cellular functions including proliferation, differentiation, cell migration and apoptosis. Alternative splicing events in the FGFR3 gene generate two isoforms, FGFR3b and FGFR3c, which have unique tissue expression patterns and ligand-binding specificity. Germline mutations in FGFR3 have been identified in syndromes of craniosynostosis, which are characterized by abnormal bone development, in addition to skin and hair follicle disorders. Somatic activating mutations in FGFR3 have been identified in up to 70% of bladder cancers and in a low percentage of other solid tumor types. In addition, a specific FGFR3 translocation is observed in approximately 15% of patients with multiple myeloma, resulting in constitutive expression of FGFR3.

Specifications

Catalog Number:
KC-4097
Cell Line Name:
Ba/F3-human-FGFR3IIIc-Cell-Line
Clone Number
Host Cell Line:
Ba/F3
Description:
Stable Ba/F3 clone expressing exogenous human FGFR3IIIc gene
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% RPMI1640+20% FBS+10% DMSO
Propagation Medium:
1640+10%FBS+1μg/mL puromycin+8ng/mL IL-3
Selection Marker:
Puromycin
Morphology:
Mostly single, round (some polymorph) cells in suspension
Subculture:
Split saturated culture 1:10 every 3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 20 hours
Mycoplasma Status:
Negative
In Vivo Validation:
NA

Cell Line Generation

BA/F3 human FGFR3IIIc cell line was generated using a lentiviral vector expressing the human FGFR3IIIc sequence.

Characterization

Figure 1: Characterization of human-FGFR3IIIc overexpression in the Ba/F3-human-FGFR3IIIc stable clone using FACS.

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 + 10% FBS+1μg/mL puromycin+8ng/mL IL-3)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:10 every 3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI-1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Alizadeh M, Miyamura N, Handa JT, Hjelmeland LM. Human RPE cells express the FGFR2IIIc and FGFR3IIIc splice variants and FGF9 as a potential high affinity ligand. Exp Eye Res. 2003 Feb;76(2):249-56. doi: 10.1016/s0014-4835(02)00252-x. PMID: 12565813.
  2. Ueno N, Shimizu A, Kanai M, Iwaya Y, Ueda S, Nakayama J, Seo MK. Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation. J Histochem Cytochem. 2016 Jan;64(1):7-17. doi: 10.1369/0022155415616161. Epub 2015 Oct 20. PMID: 26487184; PMCID: PMC4810793.
  3. Sturla LM, Merrick AE, Burchill SA. FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. Br J Cancer. 2003 Oct 6;89(7):1276-84. doi: 10.1038/sj.bjc.6601249. PMID: 14520460; PMCID: PMC2394287.